Conference Spotlight

Key takeaways, industry discussions, and insights from major regulatory conferences.

Open filters
Search
Tags
Author
Alison Sathe
Anders Vinther
Barbara W. Unger
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Mark Agostino
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Conference Spotlight

Onsite Pharma FDA Inspections During COVID-19 Respect State Restrictions

No items found.
Conference Spotlight

Desk Inspections, Missed Action Dates Take Place of FDA In-Person Site Visits

No items found.
Conference Spotlight

FDA Chooses Not to Perform Virtual Inspections in Contrast with Non-U.S. Agencies

No items found.
Conference Spotlight

Impact of the EU MDR on Combination Product Sale and Registration in the EU

No items found.
Conference Spotlight

Case Study of Contaminated WFI in China

China
GMP
pharmaceutical water
Quality
Small Pharma
Conference Spotlight

EU Animal Health Legislation Aims to Reduce Industry Burden

No items found.
Conference Spotlight

Russian Inspectorate Weighs in on Remote Audits and International Harmonization

No items found.
Conference Spotlight

FDA Combination Products Policy and Guidance Changes

No items found.
Conference Spotlight

FDA OMQ Regulatory Actions Increase Dramatically in FY2020

No items found.
Conference Spotlight

Latest Chinese Pharmacopoeia Includes Updated Chapters in Key Areas

No items found.
Conference Spotlight

FDA’s Vision for the Future of Biomanufacturing

No items found.
Conference Spotlight

89 Products Filed as NDAs Now BLAs Under Regulation Change

No items found.
Conference Spotlight

Overcoming the Quality Challenges of a CAR-T Cell Product: One Company’s Experience

No items found.
Conference Spotlight

Impact of Brexit on UK & Northern Ireland Medical Device Regulations

No items found.
Conference Spotlight

FDA Cracks Down on Unapproved HCT Products

No items found.
Conference Spotlight

Russian Drug Regulator, MHRA, and FDA Processes for Evaluating & Escalating Drug GMP Inspection Findings

No items found.
Conference Spotlight

CBER Director Wilson Bryan On How To Cut CGT Product Approval Times In Half

No items found.
Conference Spotlight

What a Scuba Diving Incident Can Teach Pharma About Quality Systems

No items found.